📈 EBV-causes-MS proof turns Epstein-Barr into a funded therapeutic target
The Harvard/US-military blood-bank paper showing Epstein-Barr infection precedes essentially every case of multiple sclerosis converts EBV from a commercially worthless nuisance ('who the hell cares about mono') into a target worth real money: T-cell therapies, mRNA vaccines, antivirals and repurposed steroids all get pulled into a newly defined, $30B-a-year indication, and Friedberg's call is that the strength of the data catalyses investment into that stack. Chamath takes the other side on healthcare economics - two-thirds of adults already carry the virus, so cost, manufacturability and ROI at population-inoculation scale get adjudicated against it.
0
CONVICTION
peaked 35.0 EMBER
DORMANT
band · contested
▲ LONG ATRA
expression · bullish equities
WRONG
result · return -73.9% · vs SPY -62.6%
2023-01-15
born 2022-01-15 (E63) → window closed
⚖ Why this result
fully deterministic — computed from daily closes on the scoring date; nothing below is editable or hand-set
- Window: 2022-01-15 → 2023-01-15 — first mention + 12-month horizon, then the window locks.
- The call: ▲ LONG ATRA (primary play). ATRA fell 73.9% over the window → return (sign flipped for a SHORT) = -73.9% (the call lost money).
- Benchmark: holding SPY over the same window returned -11.3% → vs SPY = -73.9 − (-11.3) = -62.6% — what this call made or lost against just owning the index. This is the number the result uses.
- Rule fired:
· RIGHT — return ≥ +10% AND beat SPY by 5+· HALF — return ≥ +5% OR beat SPY at all▶ WRONG — everything else
- Credit: supporters of a WRONG earn 0 each, opposers the opposite — this feeds the scoreboard. supported: Friedberg | opposed: Chamath | proxy-sensitive: MRNA→PARTIAL (+2.9%); TAK→HIT (+10.7%); XBI→PARTIAL (-7.0%)
Conviction timeline
bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15
Plays vs SPY · % since first mention (2022-01-15)
Plays
| expression | symbol | kind | relevance | rationale |
|---|---|---|---|---|
| ▲ LONG | ATRA | stock | PRIMARY | Atara Biotherapeutics is the listed pure-play on the allogeneic EBV-specific T-cell therapy modality Friedberg describes - the only instrument whose price actually responds to the EBV-MS thesis |
| ▲ LONG | MRNA | stock | adjacent | Moderna's mRNA EBV vaccine programme - the modality Jason names in-episode ('aren't we doing an mRNA vaccine for Epstein-Barr?') |
| ▲ LONG | TAK | stock | adjacent | Takeda makes maribavir, the anti-EBV antiviral Friedberg names as a possible cheap prophylactic |
| ▲ LONG | XBI | etf | adjacent | the emerging-biotech complex that absorbs the 'catalyse investment' flow into a newly validated indication |
Mention log newest first
Friedberg
equities 43% · n=123
· E71 (2022-03-05) · explicit_prediction · strength 2
▶ 1:23:38
SUPPORT
“including what we talked about a few weeks ago, multiple sclerosis, given that we now have a strong belief that if you can get rid of the EBV, the Epstein-Barr virus, from your body, you can wipe that out. So CAR-T can in the long run be harnessed not just for cancer, but autoimmunity”
Chamath
equities 42% · n=163
· E63 (2022-01-15) · sentiment · strength 2
▶ 1:12:12
OPPOSE
“two-thirds of the adult population under the age of 55 have herpes simplex 4 So you're literally talking about inoculating the entire world. ... And when we start to think about that grand of a scale, there's a cost issue, there's a manufacturability issue, and then there's an ROI issue that unfortunately will be adjudicated.”
Friedberg
equities 43% · n=123
· E63 (2022-01-15) · explicit_prediction · strength 2
▶ 1:10:36
SUPPORT
“But if Epstein-Barr virus is in fact causing this problem with MS, there's a reason to go after it, a lot of money to go after it. ... But this paper has such incredible data and such strong signal that it's really going to catalyze investment.”
Who built this conviction
each voice's total push on the score, in conviction points across every mention — supports and opposes · share = % of all mention-driven movement
⏳ decay drained -28.9 over the idea's life — that's time passing, attributed to no one
Score events
| episode | kind | Δ | after | note |
|---|---|---|---|---|
| E63 2022-01-15 | init | +35.0 | 35.0 | E63 born by Friedberg (explicit_prediction x2) |
| E63 2022-01-15 | oppose | -12.0 | 23.0 | E63 Chamath opposes x2 |
| E64 2022-01-22 | decay | -0.9 | 22.1 | E64 silent |
| E65 2022-01-29 | decay | -0.9 | 21.2 | E65 silent |
| E66 2022-02-05 | decay | -0.8 | 20.3 | E66 silent |
| E67 2022-02-12 | decay | -0.8 | 19.5 | E67 silent |
| E68 2022-02-19 | decay | -0.8 | 18.8 | E68 silent |
| E70 2022-02-24 | decay | -0.8 | 18.0 | E70 silent |
| E71 2022-03-05 | reinforce | +12.3 | 30.3 | E71 Friedberg support x2 |
| E72 2022-03-19 | decay | -1.2 | 29.1 | E72 silent |
| E73 2022-03-26 | decay | -1.2 | 27.9 | E73 silent |
| E74 2022-04-01 | decay | -1.1 | 26.8 | E74 silent |
| E75 2022-04-09 | decay | -1.1 | 25.7 | E75 silent |
| E76 2022-04-16 | decay | -1.0 | 24.7 | E76 silent |
| E77 2022-04-23 | decay | -1.0 | 23.7 | E77 silent |
| E78 2022-04-30 | decay | -0.9 | 22.8 | E78 silent |
| E79 2022-05-07 | decay | -0.9 | 21.9 | E79 silent |
| E80 2022-05-13 | decay | -0.9 | 21.0 | E80 silent |
| E81 2022-05-23 | decay | -0.8 | 20.1 | E81 silent |
| E82 2022-05-24 | decay | -0.8 | 19.3 | E82 silent |
| E84 2022-06-24 | decay | -0.8 | 18.6 | E84 silent |
| E85 2022-06-30 | decay | -0.7 | 17.8 | E85 silent |
| E86 2022-07-08 | decay | -0.7 | 17.1 | E86 silent |
| E87 2022-07-14 | decay | -0.7 | 16.4 | E87 silent |
| E88 2022-07-22 | decay | -0.7 | 15.8 | E88 silent |
| E89 2022-07-29 | decay | -0.6 | 15.1 | E89 silent |
| E90 2022-08-05 | decay | -0.6 | 14.5 | E90 silent |
| E91 2022-08-13 | decay | -0.6 | 14.0 | E91 silent |
| E92 2022-08-20 | decay | -0.6 | 13.4 | E92 silent |
| E93 2022-08-26 | decay | -0.5 | 12.9 | E93 silent |
| E94 2022-09-01 | decay | -0.5 | 12.3 | E94 silent |
| E95 2022-09-10 | decay | -0.5 | 11.9 | E95 silent |
| E96 2022-09-17 | decay | -0.5 | 11.4 | E96 silent |
| E97 2022-09-23 | decay | -0.5 | 10.9 | E97 silent |
| E98 2022-10-01 | decay | -0.4 | 10.5 | E98 silent |
| E99 2022-10-07 | decay | -0.4 | 10.1 | E99 silent |
| E100 2022-10-14 | decay | -0.4 | 9.7 | E100 silent |
| E101 2022-10-22 | decay | -0.4 | 9.3 | E101 silent |
| E102 2022-10-29 | decay | -0.4 | 8.9 | E102 silent |
| E103 2022-11-05 | decay | -0.4 | 8.5 | E103 silent |
| E105 2022-11-19 | decay | -0.3 | 8.2 | E105 silent |
| E106 2022-12-03 | decay | -0.3 | 7.9 | E106 silent |
| E107 2022-12-10 | decay | -0.3 | 7.6 | E107 silent |
| E108 2022-12-16 | decay | -0.3 | 7.3 | E108 silent |
| E109 2022-12-24 | decay | -0.3 | 7.0 | E109 silent |
| E110 2023-01-06 | decay | -0.3 | 6.7 | E110 silent |
| E111 2023-01-13 | decay | -0.3 | 6.4 | E111 silent |